nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Medroxyprogesterone Acetate—uterine cancer	0.377	1	CrCtD
Cyproterone acetate—CYP19A1—uterine cancer	0.149	1	CbGaD
Cyproterone acetate—AR—Medroxyprogesterone Acetate—uterine cancer	0.0687	0.368	CbGbCtD
Cyproterone acetate—Ethynodiol—Medroxyprogesterone Acetate—uterine cancer	0.0539	0.261	CrCrCtD
Cyproterone acetate—Ethynodiol—Progesterone—uterine cancer	0.047	0.228	CrCrCtD
Cyproterone acetate—AR—Progesterone—uterine cancer	0.0455	0.244	CbGbCtD
Cyproterone acetate—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.0437	0.234	CbGbCtD
Cyproterone acetate—Megestrol acetate—Medroxyprogesterone Acetate—uterine cancer	0.0398	0.193	CrCrCtD
Cyproterone acetate—Megestrol acetate—Progesterone—uterine cancer	0.0347	0.168	CrCrCtD
Cyproterone acetate—Medroxyprogesterone Acetate—Progesterone—uterine cancer	0.0308	0.15	CrCrCtD
Cyproterone acetate—NR3C1—Progesterone—uterine cancer	0.0289	0.155	CbGbCtD
Cyproterone acetate—CYP19A1—corpus luteum—uterine cancer	0.00446	0.252	CbGeAlD
Cyproterone acetate—CYP19A1—semen—uterine cancer	0.00209	0.118	CbGeAlD
Cyproterone acetate—AR—semen—uterine cancer	0.00185	0.104	CbGeAlD
Cyproterone acetate—AR—oviduct—uterine cancer	0.00136	0.0766	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.000522	0.0446	CbGpPWpGaD
Cyproterone acetate—AR—myometrium—uterine cancer	0.000434	0.0245	CbGeAlD
Cyproterone acetate—Ethynodiol—PGR—uterine cancer	0.000421	0.262	CrCbGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—PAWR—uterine cancer	0.000416	0.0356	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.000377	0.0322	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.000377	0.0322	CbGpPWpGaD
Cyproterone acetate—CYP19A1—endometrium—uterine cancer	0.000345	0.0195	CbGeAlD
Cyproterone acetate—AR—epithelium—uterine cancer	0.000341	0.0192	CbGeAlD
Cyproterone acetate—AR—uterine cervix—uterine cancer	0.000338	0.0191	CbGeAlD
Cyproterone acetate—AR—smooth muscle tissue—uterine cancer	0.000328	0.0185	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—AKR1C3—uterine cancer	0.000322	0.2	CrCbGaD
Cyproterone acetate—AR—decidua—uterine cancer	0.000322	0.0182	CbGeAlD
Cyproterone acetate—CYP19A1—uterus—uterine cancer	0.000318	0.0179	CbGeAlD
Cyproterone acetate—AR—renal system—uterine cancer	0.000316	0.0178	CbGeAlD
Cyproterone acetate—NR3C1—myometrium—uterine cancer	0.000315	0.0177	CbGeAlD
Cyproterone acetate—Megestrol acetate—PGR—uterine cancer	0.000307	0.191	CrCbGaD
Cyproterone acetate—AR—endometrium—uterine cancer	0.000306	0.0172	CbGeAlD
Cyproterone acetate—CYP19A1—Endogenous sterols—CYP11A1—uterine cancer	0.000301	0.0257	CbGpPWpGaD
Cyproterone acetate—AR—mammalian vulva—uterine cancer	0.000296	0.0167	CbGeAlD
Cyproterone acetate—CYP19A1—female reproductive system—uterine cancer	0.000286	0.0161	CbGeAlD
Cyproterone acetate—AR—uterus—uterine cancer	0.000282	0.0159	CbGeAlD
Cyproterone acetate—Ethynodiol—ESR1—uterine cancer	0.000266	0.165	CrCbGaD
Cyproterone acetate—CYP19A1—female gonad—uterine cancer	0.00026	0.0147	CbGeAlD
Cyproterone acetate—AR—female reproductive system—uterine cancer	0.000253	0.0143	CbGeAlD
Cyproterone acetate—NR3C1—epithelium—uterine cancer	0.000247	0.0139	CbGeAlD
Cyproterone acetate—NR3C1—uterine cervix—uterine cancer	0.000245	0.0138	CbGeAlD
Cyproterone acetate—NR3C1—smooth muscle tissue—uterine cancer	0.000238	0.0134	CbGeAlD
Cyproterone acetate—NR3C1—decidua—uterine cancer	0.000233	0.0132	CbGeAlD
Cyproterone acetate—AR—female gonad—uterine cancer	0.00023	0.013	CbGeAlD
Cyproterone acetate—AR—vagina—uterine cancer	0.000229	0.0129	CbGeAlD
Cyproterone acetate—NR3C1—renal system—uterine cancer	0.000229	0.0129	CbGeAlD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.000226	0.0193	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—MLH1—uterine cancer	0.000225	0.0192	CbGpPWpGaD
Cyproterone acetate—NR3C1—endometrium—uterine cancer	0.000221	0.0125	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptors—PGR—uterine cancer	0.000216	0.0184	CbGpPWpGaD
Cyproterone acetate—NR3C1—mammalian vulva—uterine cancer	0.000214	0.0121	CbGeAlD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—PGR—uterine cancer	0.000213	0.0182	CbGpPWpGaD
Cyproterone acetate—NR3C1—uterus—uterine cancer	0.000204	0.0115	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptors—ESR2—uterine cancer	0.00019	0.0162	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—ESR2—uterine cancer	0.000188	0.016	CbGpPWpGaD
Cyproterone acetate—NR3C1—female reproductive system—uterine cancer	0.000183	0.0103	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—PGR—uterine cancer	0.000179	0.111	CrCbGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.00017	0.0146	CbGpPWpGaD
Cyproterone acetate—CYP19A1—lymph node—uterine cancer	0.000167	0.00944	CbGeAlD
Cyproterone acetate—NR3C1—female gonad—uterine cancer	0.000167	0.00941	CbGeAlD
Cyproterone acetate—NR3C1—vagina—uterine cancer	0.000166	0.00935	CbGeAlD
Cyproterone acetate—NR3C1—Nuclear Receptors—PGR—uterine cancer	0.000164	0.014	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000157	0.0134	CbGpPWpGaD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	0.000156	0.0133	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—HNF1B—uterine cancer	0.000152	0.013	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.00015	0.0128	CbGpPWpGaD
Cyproterone acetate—AR—lymph node—uterine cancer	0.000148	0.00835	CbGeAlD
Cyproterone acetate—NR3C1—Nuclear Receptors—ESR2—uterine cancer	0.000144	0.0123	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00014	0.012	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000139	0.0119	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000138	0.0118	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000129	0.011	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—ESR1—uterine cancer	0.000115	0.00984	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000114	0.00972	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000113	0.00969	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAE—uterine cancer	0.000113	0.00969	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—ESR1—uterine cancer	0.000113	0.0703	CrCbGaD
Cyproterone acetate—NR3C1—lymph node—uterine cancer	0.000107	0.00605	CbGeAlD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000107	0.00913	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MSH6—uterine cancer	0.000103	0.00881	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—ESR1—uterine cancer	0.000102	0.00875	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—AKR1B1—uterine cancer	9.94e-05	0.00848	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—EZH2—uterine cancer	9.76e-05	0.00833	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—ESR1—uterine cancer	9.1e-05	0.00777	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IRF1—uterine cancer	9.03e-05	0.00771	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	8.88e-05	0.00758	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	8.78e-05	0.00749	CbGpPWpGaD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—uterine cancer	8.74e-05	0.00746	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—ESR1—uterine cancer	8.74e-05	0.00746	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	8.44e-05	0.00721	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MSH2—uterine cancer	8.37e-05	0.00715	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—CDKN1B—uterine cancer	7.73e-05	0.0066	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	7.71e-05	0.00658	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—AKR1C1—uterine cancer	7.29e-05	0.00623	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	7.2e-05	0.00615	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—SMAD3—uterine cancer	7.15e-05	0.0061	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—CDKN1B—uterine cancer	6.96e-05	0.00595	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—ESR1—uterine cancer	6.91e-05	0.0059	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—SMAD3—uterine cancer	6.72e-05	0.00574	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—YWHAE—uterine cancer	6.65e-05	0.00568	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CDKN1B—uterine cancer	6.61e-05	0.00564	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GPX3—uterine cancer	6.4e-05	0.00547	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	6.4e-05	0.00547	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	6.29e-05	0.00537	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—ESR2—uterine cancer	6.14e-05	0.00524	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—HMGA1—uterine cancer	6.12e-05	0.00523	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—EP300—uterine cancer	6.12e-05	0.00522	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—uterine cancer	6.06e-05	0.00517	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP11A1—uterine cancer	6.03e-05	0.00515	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—PIK3CA—uterine cancer	5.99e-05	0.00511	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP11A1—uterine cancer	5.95e-05	0.00508	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	5.85e-05	0.00499	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—EP300—uterine cancer	5.8e-05	0.00495	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—STK11—uterine cancer	5.72e-05	0.00488	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	5.72e-05	0.00488	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	5.63e-05	0.00481	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—AKR1C3—uterine cancer	5.61e-05	0.00479	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—HRAS—uterine cancer	5.54e-05	0.00473	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—uterine cancer	5.52e-05	0.00472	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—ESR1—uterine cancer	5.36e-05	0.00458	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.35e-05	0.00457	CbGpPWpGaD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—uterine cancer	5.33e-05	0.00455	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—EP300—uterine cancer	5.27e-05	0.0045	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	5.22e-05	0.00446	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CTNNB1—uterine cancer	5.07e-05	0.00433	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—YWHAE—uterine cancer	5.05e-05	0.00431	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—STK11—uterine cancer	4.92e-05	0.0042	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—AKT1—uterine cancer	4.89e-05	0.00418	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—uterine cancer	4.87e-05	0.00416	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	4.77e-05	0.00407	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	4.74e-05	0.00405	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCL2—uterine cancer	4.72e-05	0.00403	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AKT1—uterine cancer	4.7e-05	0.00401	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—ESR2—uterine cancer	4.66e-05	0.00398	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—SOCS3—uterine cancer	4.58e-05	0.00391	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—uterine cancer	4.42e-05	0.00377	CbGpPWpGaD
Cyproterone acetate—Fluid retention—Doxorubicin—uterine cancer	4.32e-05	0.000868	CcSEcCtD
Cyproterone acetate—Abnormal vision—Epirubicin—uterine cancer	4.29e-05	0.000862	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	4.25e-05	0.00363	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Dactinomycin—uterine cancer	4.24e-05	0.000851	CcSEcCtD
Cyproterone acetate—Diarrhoea—Progesterone—uterine cancer	4.19e-05	0.000842	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Etoposide—uterine cancer	4.17e-05	0.000837	CcSEcCtD
Cyproterone acetate—Coma—Doxorubicin—uterine cancer	4.16e-05	0.000836	CcSEcCtD
Cyproterone acetate—Phlebitis—Epirubicin—uterine cancer	4.15e-05	0.000833	CcSEcCtD
Cyproterone acetate—Rash maculo-papular—Doxorubicin—uterine cancer	4.14e-05	0.000831	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Epirubicin—uterine cancer	4.13e-05	0.000829	CcSEcCtD
Cyproterone acetate—Anorexia—Dactinomycin—uterine cancer	4.13e-05	0.000829	CcSEcCtD
Cyproterone acetate—Eye disorder—Etoposide—uterine cancer	4.12e-05	0.000828	CcSEcCtD
Cyproterone acetate—Neoplasm—Doxorubicin—uterine cancer	4.12e-05	0.000827	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—uterine cancer	4.11e-05	0.00351	CbGpPWpGaD
Cyproterone acetate—Diabetes mellitus—Epirubicin—uterine cancer	4.11e-05	0.000825	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	4.09e-05	0.000821	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—uterine cancer	4.08e-05	0.00348	CbGpPWpGaD
Cyproterone acetate—Dizziness—Progesterone—uterine cancer	4.05e-05	0.000813	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—SMAD3—uterine cancer	4e-05	0.00342	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Etoposide—uterine cancer	4e-05	0.000804	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—EP300—uterine cancer	4e-05	0.00341	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PHF1—uterine cancer	4e-05	0.00341	CbGpPWpGaD
Cyproterone acetate—Immune system disorder—Etoposide—uterine cancer	3.98e-05	0.0008	CcSEcCtD
Cyproterone acetate—Asthenia—Medroxyprogesterone Acetate—uterine cancer	3.98e-05	0.0008	CcSEcCtD
Cyproterone acetate—Eczema—Epirubicin—uterine cancer	3.97e-05	0.000799	CcSEcCtD
Cyproterone acetate—Hepatic failure—Epirubicin—uterine cancer	3.97e-05	0.000799	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Etoposide—uterine cancer	3.97e-05	0.000798	CcSEcCtD
Cyproterone acetate—Abnormal vision—Doxorubicin—uterine cancer	3.97e-05	0.000798	CcSEcCtD
Cyproterone acetate—Chills—Etoposide—uterine cancer	3.96e-05	0.000795	CcSEcCtD
Cyproterone acetate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	3.93e-05	0.000789	CcSEcCtD
Cyproterone acetate—Alopecia—Etoposide—uterine cancer	3.9e-05	0.000783	CcSEcCtD
Cyproterone acetate—Vomiting—Progesterone—uterine cancer	3.89e-05	0.000782	CcSEcCtD
Cyproterone acetate—NR3C1—Circadian Clock—EP300—uterine cancer	3.88e-05	0.00331	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.87e-05	0.0033	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.87e-05	0.0033	CbGpPWpGaD
Cyproterone acetate—Rash—Progesterone—uterine cancer	3.86e-05	0.000776	CcSEcCtD
Cyproterone acetate—Dermatitis—Progesterone—uterine cancer	3.86e-05	0.000775	CcSEcCtD
Cyproterone acetate—Phlebitis—Doxorubicin—uterine cancer	3.84e-05	0.000771	CcSEcCtD
Cyproterone acetate—Headache—Progesterone—uterine cancer	3.84e-05	0.000771	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ESR1—uterine cancer	3.82e-05	0.00326	CbGpPWpGaD
Cyproterone acetate—Hot flush—Epirubicin—uterine cancer	3.82e-05	0.000767	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Doxorubicin—uterine cancer	3.82e-05	0.000767	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Doxorubicin—uterine cancer	3.8e-05	0.000763	CcSEcCtD
Cyproterone acetate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	3.8e-05	0.000763	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—uterine cancer	3.79e-05	0.00324	CbGpPWpGaD
Cyproterone acetate—Menopausal symptoms—Epirubicin—uterine cancer	3.79e-05	0.000761	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Epirubicin—uterine cancer	3.79e-05	0.000761	CcSEcCtD
Cyproterone acetate—Decreased appetite—Dactinomycin—uterine cancer	3.76e-05	0.000756	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	3.75e-05	0.0032	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CTNNB1—uterine cancer	3.74e-05	0.0032	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CXCL8—uterine cancer	3.73e-05	0.00319	CbGpPWpGaD
Cyproterone acetate—Fatigue—Dactinomycin—uterine cancer	3.73e-05	0.00075	CcSEcCtD
Cyproterone acetate—Eczema—Doxorubicin—uterine cancer	3.68e-05	0.000739	CcSEcCtD
Cyproterone acetate—Hepatic failure—Doxorubicin—uterine cancer	3.68e-05	0.000739	CcSEcCtD
Cyproterone acetate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	3.67e-05	0.000737	CcSEcCtD
Cyproterone acetate—Cardiac failure—Epirubicin—uterine cancer	3.66e-05	0.000735	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PTEN—uterine cancer	3.65e-05	0.00312	CbGpPWpGaD
Cyproterone acetate—Cerebrovascular accident—Epirubicin—uterine cancer	3.65e-05	0.000732	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN1B—uterine cancer	3.64e-05	0.00311	CbGpPWpGaD
Cyproterone acetate—Nausea—Progesterone—uterine cancer	3.64e-05	0.000731	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Dactinomycin—uterine cancer	3.57e-05	0.000716	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Etoposide—uterine cancer	3.56e-05	0.000715	CcSEcCtD
Cyproterone acetate—Anaemia—Etoposide—uterine cancer	3.55e-05	0.000713	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Dactinomycin—uterine cancer	3.54e-05	0.000711	CcSEcCtD
Cyproterone acetate—Hot flush—Doxorubicin—uterine cancer	3.53e-05	0.00071	CcSEcCtD
Cyproterone acetate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	3.53e-05	0.000709	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—CTNNB1—uterine cancer	3.52e-05	0.00301	CbGpPWpGaD
Cyproterone acetate—Affect lability—Epirubicin—uterine cancer	3.52e-05	0.000706	CcSEcCtD
Cyproterone acetate—Migraine—Epirubicin—uterine cancer	3.52e-05	0.000706	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Doxorubicin—uterine cancer	3.5e-05	0.000704	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Doxorubicin—uterine cancer	3.5e-05	0.000704	CcSEcCtD
Cyproterone acetate—Rash—Medroxyprogesterone Acetate—uterine cancer	3.5e-05	0.000703	CcSEcCtD
Cyproterone acetate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	3.49e-05	0.000702	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EP300—uterine cancer	3.48e-05	0.00297	CbGpPWpGaD
Cyproterone acetate—Headache—Medroxyprogesterone Acetate—uterine cancer	3.48e-05	0.000698	CcSEcCtD
Cyproterone acetate—Malaise—Etoposide—uterine cancer	3.46e-05	0.000695	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CTNNB1—uterine cancer	3.44e-05	0.00294	CbGpPWpGaD
Cyproterone acetate—Leukopenia—Etoposide—uterine cancer	3.44e-05	0.00069	CcSEcCtD
Cyproterone acetate—Abdominal pain—Dactinomycin—uterine cancer	3.42e-05	0.000687	CcSEcCtD
Cyproterone acetate—Body temperature increased—Dactinomycin—uterine cancer	3.42e-05	0.000687	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—CHD4—uterine cancer	3.4e-05	0.0029	CbGpPWpGaD
Cyproterone acetate—Cardiac failure—Doxorubicin—uterine cancer	3.39e-05	0.00068	CcSEcCtD
Cyproterone acetate—Mood swings—Epirubicin—uterine cancer	3.38e-05	0.00068	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Etoposide—uterine cancer	3.37e-05	0.000678	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Doxorubicin—uterine cancer	3.37e-05	0.000678	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PTEN—uterine cancer	3.36e-05	0.00287	CbGpPWpGaD
Cyproterone acetate—Cough—Etoposide—uterine cancer	3.35e-05	0.000673	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Epirubicin—uterine cancer	3.35e-05	0.000672	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDH1—uterine cancer	3.32e-05	0.00284	CbGpPWpGaD
Cyproterone acetate—Liver function test abnormal—Epirubicin—uterine cancer	3.3e-05	0.000663	CcSEcCtD
Cyproterone acetate—Nausea—Medroxyprogesterone Acetate—uterine cancer	3.3e-05	0.000662	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—uterine cancer	3.29e-05	0.00281	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—uterine cancer	3.29e-05	0.00281	CbGpPWpGaD
Cyproterone acetate—Affect lability—Doxorubicin—uterine cancer	3.25e-05	0.000654	CcSEcCtD
Cyproterone acetate—Migraine—Doxorubicin—uterine cancer	3.25e-05	0.000654	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	3.24e-05	0.000652	CcSEcCtD
Cyproterone acetate—Discomfort—Etoposide—uterine cancer	3.23e-05	0.000648	CcSEcCtD
Cyproterone acetate—Breast disorder—Epirubicin—uterine cancer	3.23e-05	0.000648	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Epirubicin—uterine cancer	3.22e-05	0.000646	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—EP300—uterine cancer	3.2e-05	0.00273	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Dactinomycin—uterine cancer	3.19e-05	0.000641	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	3.17e-05	0.0027	CbGpPWpGaD
Cyproterone acetate—Muscular weakness—Epirubicin—uterine cancer	3.15e-05	0.000633	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Epirubicin—uterine cancer	3.15e-05	0.000633	CcSEcCtD
Cyproterone acetate—Mood swings—Doxorubicin—uterine cancer	3.13e-05	0.000629	CcSEcCtD
Cyproterone acetate—Asthenia—Dactinomycin—uterine cancer	3.1e-05	0.000624	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Doxorubicin—uterine cancer	3.1e-05	0.000622	CcSEcCtD
Cyproterone acetate—Asthma—Epirubicin—uterine cancer	3.09e-05	0.00062	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Etoposide—uterine cancer	3.07e-05	0.000616	CcSEcCtD
Cyproterone acetate—Tachycardia—Etoposide—uterine cancer	3.06e-05	0.000614	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Doxorubicin—uterine cancer	3.05e-05	0.000613	CcSEcCtD
Cyproterone acetate—Skin disorder—Etoposide—uterine cancer	3.04e-05	0.000611	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—PHF1—uterine cancer	3.03e-05	0.00259	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Etoposide—uterine cancer	3.03e-05	0.000608	CcSEcCtD
Cyproterone acetate—Pancreatitis—Epirubicin—uterine cancer	3.03e-05	0.000608	CcSEcCtD
Cyproterone acetate—Breast disorder—Doxorubicin—uterine cancer	2.99e-05	0.0006	CcSEcCtD
Cyproterone acetate—Anorexia—Etoposide—uterine cancer	2.99e-05	0.0006	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	2.98e-05	0.000598	CcSEcCtD
Cyproterone acetate—Diarrhoea—Dactinomycin—uterine cancer	2.96e-05	0.000595	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—PGR—uterine cancer	2.94e-05	0.00251	CbGpPWpGaD
Cyproterone acetate—Hypotension—Etoposide—uterine cancer	2.93e-05	0.000588	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Doxorubicin—uterine cancer	2.92e-05	0.000586	CcSEcCtD
Cyproterone acetate—Muscular weakness—Doxorubicin—uterine cancer	2.92e-05	0.000586	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	2.86e-05	0.00244	CbGpPWpGaD
Cyproterone acetate—Asthma—Doxorubicin—uterine cancer	2.86e-05	0.000574	CcSEcCtD
Cyproterone acetate—Pollakiuria—Epirubicin—uterine cancer	2.85e-05	0.000573	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	2.85e-05	0.00243	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SUZ12—uterine cancer	2.85e-05	0.00243	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—uterine cancer	2.85e-05	0.00243	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.84e-05	0.00242	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—EP300—uterine cancer	2.82e-05	0.00241	CbGpPWpGaD
Cyproterone acetate—Photosensitivity reaction—Epirubicin—uterine cancer	2.82e-05	0.000566	CcSEcCtD
Cyproterone acetate—Weight increased—Epirubicin—uterine cancer	2.81e-05	0.000564	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	2.8e-05	0.00239	CbGpPWpGaD
Cyproterone acetate—Pancreatitis—Doxorubicin—uterine cancer	2.8e-05	0.000563	CcSEcCtD
Cyproterone acetate—Weight decreased—Epirubicin—uterine cancer	2.79e-05	0.000561	CcSEcCtD
Cyproterone acetate—Dyspnoea—Etoposide—uterine cancer	2.79e-05	0.000561	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Epirubicin—uterine cancer	2.78e-05	0.000559	CcSEcCtD
Cyproterone acetate—Vomiting—Dactinomycin—uterine cancer	2.75e-05	0.000553	CcSEcCtD
Cyproterone acetate—Rash—Dactinomycin—uterine cancer	2.73e-05	0.000548	CcSEcCtD
Cyproterone acetate—Decreased appetite—Etoposide—uterine cancer	2.72e-05	0.000547	CcSEcCtD
Cyproterone acetate—Renal failure—Epirubicin—uterine cancer	2.71e-05	0.000544	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Etoposide—uterine cancer	2.7e-05	0.000543	CcSEcCtD
Cyproterone acetate—Fatigue—Etoposide—uterine cancer	2.7e-05	0.000542	CcSEcCtD
Cyproterone acetate—Jaundice—Epirubicin—uterine cancer	2.68e-05	0.000539	CcSEcCtD
Cyproterone acetate—Constipation—Etoposide—uterine cancer	2.68e-05	0.000538	CcSEcCtD
Cyproterone acetate—Sweating—Epirubicin—uterine cancer	2.64e-05	0.00053	CcSEcCtD
Cyproterone acetate—Pollakiuria—Doxorubicin—uterine cancer	2.64e-05	0.00053	CcSEcCtD
Cyproterone acetate—Haematuria—Epirubicin—uterine cancer	2.62e-05	0.000527	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Doxorubicin—uterine cancer	2.61e-05	0.000524	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Epirubicin—uterine cancer	2.6e-05	0.000523	CcSEcCtD
Cyproterone acetate—Weight increased—Doxorubicin—uterine cancer	2.6e-05	0.000522	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR2—uterine cancer	2.59e-05	0.00221	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CXCL8—uterine cancer	2.59e-05	0.00221	CbGpPWpGaD
Cyproterone acetate—Weight decreased—Doxorubicin—uterine cancer	2.58e-05	0.000519	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Etoposide—uterine cancer	2.58e-05	0.000519	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—CHD4—uterine cancer	2.58e-05	0.0022	CbGpPWpGaD
Cyproterone acetate—Hyperglycaemia—Doxorubicin—uterine cancer	2.58e-05	0.000518	CcSEcCtD
Cyproterone acetate—Nausea—Dactinomycin—uterine cancer	2.57e-05	0.000516	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Etoposide—uterine cancer	2.56e-05	0.000515	CcSEcCtD
Cyproterone acetate—Renal failure—Doxorubicin—uterine cancer	2.5e-05	0.000503	CcSEcCtD
Cyproterone acetate—Urticaria—Etoposide—uterine cancer	2.49e-05	0.0005	CcSEcCtD
Cyproterone acetate—Haemoglobin—Epirubicin—uterine cancer	2.48e-05	0.000499	CcSEcCtD
Cyproterone acetate—Jaundice—Doxorubicin—uterine cancer	2.48e-05	0.000499	CcSEcCtD
Cyproterone acetate—Body temperature increased—Etoposide—uterine cancer	2.48e-05	0.000497	CcSEcCtD
Cyproterone acetate—Abdominal pain—Etoposide—uterine cancer	2.48e-05	0.000497	CcSEcCtD
Cyproterone acetate—Hepatitis—Epirubicin—uterine cancer	2.47e-05	0.000496	CcSEcCtD
Cyproterone acetate—Haemorrhage—Epirubicin—uterine cancer	2.47e-05	0.000496	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.45e-05	0.00209	CbGpPWpGaD
Cyproterone acetate—Sweating—Doxorubicin—uterine cancer	2.44e-05	0.000491	CcSEcCtD
Cyproterone acetate—Haematuria—Doxorubicin—uterine cancer	2.43e-05	0.000488	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Epirubicin—uterine cancer	2.43e-05	0.000488	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Doxorubicin—uterine cancer	2.41e-05	0.000484	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.39e-05	0.00204	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	2.39e-05	0.00204	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SRD5A2—uterine cancer	2.38e-05	0.00203	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NDUFB11—uterine cancer	2.38e-05	0.00203	CbGpPWpGaD
Cyproterone acetate—Visual impairment—Epirubicin—uterine cancer	2.38e-05	0.000478	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Epirubicin—uterine cancer	2.34e-05	0.000469	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.32e-05	0.00198	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.31e-05	0.00198	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Epirubicin—uterine cancer	2.31e-05	0.000464	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Etoposide—uterine cancer	2.31e-05	0.000464	CcSEcCtD
Cyproterone acetate—Haemoglobin—Doxorubicin—uterine cancer	2.3e-05	0.000462	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	2.29e-05	0.00196	CbGpPWpGaD
Cyproterone acetate—Haemorrhage—Doxorubicin—uterine cancer	2.29e-05	0.000459	CcSEcCtD
Cyproterone acetate—Hepatitis—Doxorubicin—uterine cancer	2.29e-05	0.000459	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EP300—uterine cancer	2.28e-05	0.00195	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	2.27e-05	0.00194	CbGpPWpGaD
Cyproterone acetate—Asthenia—Etoposide—uterine cancer	2.25e-05	0.000451	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—uterine cancer	2.25e-05	0.000451	CcSEcCtD
Cyproterone acetate—Angiopathy—Epirubicin—uterine cancer	2.24e-05	0.00045	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	2.23e-05	0.00191	CbGpPWpGaD
Cyproterone acetate—Immune system disorder—Epirubicin—uterine cancer	2.23e-05	0.000448	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Epirubicin—uterine cancer	2.23e-05	0.000447	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—EP300—uterine cancer	2.22e-05	0.0019	CbGpPWpGaD
Cyproterone acetate—Chills—Epirubicin—uterine cancer	2.22e-05	0.000445	CcSEcCtD
Cyproterone acetate—Pruritus—Etoposide—uterine cancer	2.22e-05	0.000445	CcSEcCtD
Cyproterone acetate—Visual impairment—Doxorubicin—uterine cancer	2.2e-05	0.000443	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.19e-05	0.00187	CbGpPWpGaD
Cyproterone acetate—Alopecia—Epirubicin—uterine cancer	2.18e-05	0.000439	CcSEcCtD
Cyproterone acetate—Mental disorder—Epirubicin—uterine cancer	2.16e-05	0.000435	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Doxorubicin—uterine cancer	2.16e-05	0.000434	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—SUZ12—uterine cancer	2.16e-05	0.00184	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	2.16e-05	0.00184	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.15e-05	0.00184	CbGpPWpGaD
Cyproterone acetate—Malnutrition—Epirubicin—uterine cancer	2.15e-05	0.000432	CcSEcCtD
Cyproterone acetate—Diarrhoea—Etoposide—uterine cancer	2.14e-05	0.000431	CcSEcCtD
Cyproterone acetate—Eye disorder—Doxorubicin—uterine cancer	2.14e-05	0.000429	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.11e-05	0.0018	CbGpPWpGaD
Cyproterone acetate—Tension—Epirubicin—uterine cancer	2.11e-05	0.000424	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—CDKN2B—uterine cancer	2.11e-05	0.0018	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—uterine cancer	2.1e-05	0.0018	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—uterine cancer	2.1e-05	0.0018	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CTNNB1—uterine cancer	2.1e-05	0.00179	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Doxorubicin—uterine cancer	2.07e-05	0.000417	CcSEcCtD
Cyproterone acetate—Dizziness—Etoposide—uterine cancer	2.07e-05	0.000416	CcSEcCtD
Cyproterone acetate—Immune system disorder—Doxorubicin—uterine cancer	2.07e-05	0.000415	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—uterine cancer	2.06e-05	0.000414	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.06e-05	0.00176	CbGpPWpGaD
Cyproterone acetate—Chills—Doxorubicin—uterine cancer	2.05e-05	0.000412	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.03e-05	0.00174	CbGpPWpGaD
Cyproterone acetate—Alopecia—Doxorubicin—uterine cancer	2.02e-05	0.000406	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	2.02e-05	0.00172	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Doxorubicin—uterine cancer	2e-05	0.000402	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Epirubicin—uterine cancer	2e-05	0.000401	CcSEcCtD
Cyproterone acetate—Vomiting—Etoposide—uterine cancer	1.99e-05	0.0004	CcSEcCtD
Cyproterone acetate—Malnutrition—Doxorubicin—uterine cancer	1.99e-05	0.0004	CcSEcCtD
Cyproterone acetate—Anaemia—Epirubicin—uterine cancer	1.99e-05	0.000399	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.98e-05	0.00169	CbGpPWpGaD
Cyproterone acetate—Agitation—Epirubicin—uterine cancer	1.98e-05	0.000397	CcSEcCtD
Cyproterone acetate—Rash—Etoposide—uterine cancer	1.97e-05	0.000397	CcSEcCtD
Cyproterone acetate—Dermatitis—Etoposide—uterine cancer	1.97e-05	0.000396	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	1.97e-05	0.00168	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	1.97e-05	0.00168	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.96e-05	0.00168	CbGpPWpGaD
Cyproterone acetate—Headache—Etoposide—uterine cancer	1.96e-05	0.000394	CcSEcCtD
Cyproterone acetate—Tension—Doxorubicin—uterine cancer	1.95e-05	0.000392	CcSEcCtD
Cyproterone acetate—Malaise—Epirubicin—uterine cancer	1.94e-05	0.00039	CcSEcCtD
Cyproterone acetate—Syncope—Epirubicin—uterine cancer	1.93e-05	0.000388	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—SMAD3—uterine cancer	1.93e-05	0.00165	CbGpPWpGaD
Cyproterone acetate—Leukopenia—Epirubicin—uterine cancer	1.93e-05	0.000387	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Epirubicin—uterine cancer	1.89e-05	0.00038	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.89e-05	0.00161	CbGpPWpGaD
Cyproterone acetate—Cough—Epirubicin—uterine cancer	1.88e-05	0.000377	CcSEcCtD
Cyproterone acetate—Nausea—Etoposide—uterine cancer	1.86e-05	0.000374	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.86e-05	0.00159	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—uterine cancer	1.85e-05	0.000371	CcSEcCtD
Cyproterone acetate—Anaemia—Doxorubicin—uterine cancer	1.84e-05	0.00037	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.84e-05	0.00157	CbGpPWpGaD
Cyproterone acetate—Agitation—Doxorubicin—uterine cancer	1.83e-05	0.000367	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	1.82e-05	0.000365	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	1.81e-05	0.00155	CbGpPWpGaD
Cyproterone acetate—Discomfort—Epirubicin—uterine cancer	1.81e-05	0.000364	CcSEcCtD
Cyproterone acetate—Malaise—Doxorubicin—uterine cancer	1.79e-05	0.000361	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.79e-05	0.00153	CbGpPWpGaD
Cyproterone acetate—Syncope—Doxorubicin—uterine cancer	1.78e-05	0.000359	CcSEcCtD
Cyproterone acetate—Leukopenia—Doxorubicin—uterine cancer	1.78e-05	0.000358	CcSEcCtD
Cyproterone acetate—Oedema—Epirubicin—uterine cancer	1.76e-05	0.000353	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Doxorubicin—uterine cancer	1.75e-05	0.000351	CcSEcCtD
Cyproterone acetate—Cough—Doxorubicin—uterine cancer	1.74e-05	0.000349	CcSEcCtD
Cyproterone acetate—Shock—Epirubicin—uterine cancer	1.73e-05	0.000347	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—AKR1B1—uterine cancer	1.72e-05	0.00147	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—STAR—uterine cancer	1.72e-05	0.00147	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Epirubicin—uterine cancer	1.72e-05	0.000346	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.72e-05	0.00147	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Epirubicin—uterine cancer	1.72e-05	0.000345	CcSEcCtD
Cyproterone acetate—Tachycardia—Epirubicin—uterine cancer	1.71e-05	0.000344	CcSEcCtD
Cyproterone acetate—Skin disorder—Epirubicin—uterine cancer	1.71e-05	0.000343	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	1.7e-05	0.00145	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Epirubicin—uterine cancer	1.7e-05	0.000341	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	1.69e-05	0.00144	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	1.68e-05	0.000338	CcSEcCtD
Cyproterone acetate—Discomfort—Doxorubicin—uterine cancer	1.67e-05	0.000336	CcSEcCtD
Cyproterone acetate—Anorexia—Epirubicin—uterine cancer	1.67e-05	0.000336	CcSEcCtD
Cyproterone acetate—Hypotension—Epirubicin—uterine cancer	1.64e-05	0.00033	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.63e-05	0.00139	CbGpPWpGaD
Cyproterone acetate—Oedema—Doxorubicin—uterine cancer	1.62e-05	0.000326	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	1.6e-05	0.00137	CbGpPWpGaD
Cyproterone acetate—Shock—Doxorubicin—uterine cancer	1.6e-05	0.000321	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.6e-05	0.00136	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Doxorubicin—uterine cancer	1.59e-05	0.00032	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—uterine cancer	1.59e-05	0.00032	CcSEcCtD
Cyproterone acetate—Tachycardia—Doxorubicin—uterine cancer	1.59e-05	0.000319	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.58e-05	0.00135	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Doxorubicin—uterine cancer	1.58e-05	0.000317	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR1—uterine cancer	1.57e-05	0.00134	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—uterine cancer	1.57e-05	0.000315	CcSEcCtD
Cyproterone acetate—Dyspnoea—Epirubicin—uterine cancer	1.57e-05	0.000314	CcSEcCtD
Cyproterone acetate—Anorexia—Doxorubicin—uterine cancer	1.55e-05	0.000311	CcSEcCtD
Cyproterone acetate—Dyspepsia—Epirubicin—uterine cancer	1.55e-05	0.00031	CcSEcCtD
Cyproterone acetate—Decreased appetite—Epirubicin—uterine cancer	1.53e-05	0.000307	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.52e-05	0.0013	CbGpPWpGaD
Cyproterone acetate—Hypotension—Doxorubicin—uterine cancer	1.52e-05	0.000305	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Epirubicin—uterine cancer	1.52e-05	0.000304	CcSEcCtD
Cyproterone acetate—Fatigue—Epirubicin—uterine cancer	1.51e-05	0.000304	CcSEcCtD
Cyproterone acetate—Constipation—Epirubicin—uterine cancer	1.5e-05	0.000302	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	1.46e-05	0.00125	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Doxorubicin—uterine cancer	1.45e-05	0.000291	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Epirubicin—uterine cancer	1.45e-05	0.000291	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Epirubicin—uterine cancer	1.44e-05	0.000288	CcSEcCtD
Cyproterone acetate—Dyspepsia—Doxorubicin—uterine cancer	1.43e-05	0.000287	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—PGR—uterine cancer	1.42e-05	0.00121	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Doxorubicin—uterine cancer	1.41e-05	0.000284	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.4e-05	0.0012	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—uterine cancer	1.4e-05	0.000282	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—uterine cancer	1.4e-05	0.000281	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.4e-05	0.00119	CbGpPWpGaD
Cyproterone acetate—Urticaria—Epirubicin—uterine cancer	1.39e-05	0.00028	CcSEcCtD
Cyproterone acetate—Constipation—Doxorubicin—uterine cancer	1.39e-05	0.000279	CcSEcCtD
Cyproterone acetate—Abdominal pain—Epirubicin—uterine cancer	1.39e-05	0.000279	CcSEcCtD
Cyproterone acetate—Body temperature increased—Epirubicin—uterine cancer	1.39e-05	0.000279	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.38e-05	0.00118	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.35e-05	0.00115	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—POLD1—uterine cancer	1.35e-05	0.00115	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—EZH2—uterine cancer	1.35e-05	0.00115	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Doxorubicin—uterine cancer	1.34e-05	0.000269	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—uterine cancer	1.33e-05	0.000267	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Epirubicin—uterine cancer	1.29e-05	0.00026	CcSEcCtD
Cyproterone acetate—Urticaria—Doxorubicin—uterine cancer	1.29e-05	0.000259	CcSEcCtD
Cyproterone acetate—Body temperature increased—Doxorubicin—uterine cancer	1.28e-05	0.000258	CcSEcCtD
Cyproterone acetate—Abdominal pain—Doxorubicin—uterine cancer	1.28e-05	0.000258	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—AKR1C1—uterine cancer	1.26e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—Asthenia—Epirubicin—uterine cancer	1.26e-05	0.000253	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—ESR2—uterine cancer	1.25e-05	0.00107	CbGpPWpGaD
Cyproterone acetate—Pruritus—Epirubicin—uterine cancer	1.24e-05	0.00025	CcSEcCtD
Cyproterone acetate—Diarrhoea—Epirubicin—uterine cancer	1.2e-05	0.000241	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Doxorubicin—uterine cancer	1.2e-05	0.00024	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	1.19e-05	0.00102	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.19e-05	0.00101	CbGpPWpGaD
Cyproterone acetate—Asthenia—Doxorubicin—uterine cancer	1.17e-05	0.000234	CcSEcCtD
Cyproterone acetate—Dizziness—Epirubicin—uterine cancer	1.16e-05	0.000233	CcSEcCtD
Cyproterone acetate—Pruritus—Doxorubicin—uterine cancer	1.15e-05	0.000231	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.14e-05	0.000975	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—RRM2—uterine cancer	1.13e-05	0.000962	CbGpPWpGaD
Cyproterone acetate—Vomiting—Epirubicin—uterine cancer	1.12e-05	0.000224	CcSEcCtD
Cyproterone acetate—Diarrhoea—Doxorubicin—uterine cancer	1.11e-05	0.000223	CcSEcCtD
Cyproterone acetate—Rash—Epirubicin—uterine cancer	1.11e-05	0.000222	CcSEcCtD
Cyproterone acetate—Dermatitis—Epirubicin—uterine cancer	1.11e-05	0.000222	CcSEcCtD
Cyproterone acetate—Headache—Epirubicin—uterine cancer	1.1e-05	0.000221	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—DCN—uterine cancer	1.09e-05	0.000934	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PGR—uterine cancer	1.08e-05	0.000919	CbGpPWpGaD
Cyproterone acetate—Dizziness—Doxorubicin—uterine cancer	1.07e-05	0.000216	CcSEcCtD
Cyproterone acetate—Nausea—Epirubicin—uterine cancer	1.04e-05	0.000209	CcSEcCtD
Cyproterone acetate—Vomiting—Doxorubicin—uterine cancer	1.03e-05	0.000207	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.00088	CbGpPWpGaD
Cyproterone acetate—Rash—Doxorubicin—uterine cancer	1.02e-05	0.000206	CcSEcCtD
Cyproterone acetate—Dermatitis—Doxorubicin—uterine cancer	1.02e-05	0.000206	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EZH2—uterine cancer	1.02e-05	0.000872	CbGpPWpGaD
Cyproterone acetate—Headache—Doxorubicin—uterine cancer	1.02e-05	0.000204	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—CDKN2B—uterine cancer	1.02e-05	0.000868	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKR1C3—uterine cancer	9.73e-06	0.000831	CbGpPWpGaD
Cyproterone acetate—Nausea—Doxorubicin—uterine cancer	9.65e-06	0.000194	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—ESR2—uterine cancer	9.47e-06	0.000809	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SMAD3—uterine cancer	9.28e-06	0.000792	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CDKN2B—uterine cancer	7.71e-06	0.000658	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—STK11—uterine cancer	7.58e-06	0.000648	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR1—uterine cancer	7.57e-06	0.000646	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.12e-06	0.000608	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SMAD3—uterine cancer	7.04e-06	0.000601	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.79e-06	0.00058	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR1—uterine cancer	5.74e-06	0.00049	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—uterine cancer	5.7e-06	0.000487	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.02e-06	0.000429	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—uterine cancer	3.17e-06	0.000271	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—EP300—uterine cancer	3.02e-06	0.000258	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—uterine cancer	2.73e-06	0.000233	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—uterine cancer	2.24e-06	0.000191	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—uterine cancer	2.07e-06	0.000177	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—uterine cancer	1.83e-06	0.000156	CbGpPWpGaD
